Monoclonal antibodies in the treatment of colorectal cancer
- 30 June 2004
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (9) , 1292-1301
- https://doi.org/10.1016/j.ejca.2004.02.014
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Monoclonal antibodies as therapeutics in oncologyCurrent Opinion in Biotechnology, 2002
- Chemotherapy for colorectal cancerHematology/Oncology Clinics of North America, 2002
- Magic Bullets Fly AgainScientific American, 2001
- Cancer burden in the year 2000. The global picturePublished by Elsevier ,2001
- Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinomaCritical Reviews in Oncology/Hematology, 2001
- The biology of the 17–1A antigen (Ep-CAM)Journal of Molecular Medicine, 1999
- Colorectal cancerThe Lancet, 1999
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1997